Post by
SmartPodhotzone on Dec 20, 2020 10:02am
Based on my research
A 10-year cohort study was performed, involving all of the 118 patients treated with bucillamine in our hospital between 1988 and 1990. Evaluation was made ..The 100 patients who dropped out could be roughly divided into three groups. One third of them dropped out because of lack of or attenuation of response. Another third dropped out because of referral to other medical facilities or discontinuation of visits to our hospital, and the remaining third dropped out because of adverse reactions to treatment.
Comment by
SmartPodhotzone on Dec 20, 2020 10:06am
Ask yourself how come not one medical related institution even involved here ...cause they already know based on data from 20 years ..any adverse effects ..and no FDA